IP Verse

Aluminium Compounds For Use In Therapeutics And Vaccines - EP3785730

The patent EP3785730 was granted to Valneva Austria on Apr 24, 2024. The application was originally filed on Dec 6, 2012 under application number EP20184308A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3785730

VALNEVA AUSTRIA
Application Number
EP20184308A
Filing Date
Dec 6, 2012
Status
Granted And Under Opposition
Mar 22, 2024
Grant Date
Apr 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJan 24, 2025PLASSERAUDADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONCN101734698
DESCRIPTIONEP0497524
DESCRIPTIONEP0497525
DESCRIPTIONUS4057685
DESCRIPTIONUS4459286
DESCRIPTIONUS4663160
DESCRIPTIONUS4673574
DESCRIPTIONUS4695624
DESCRIPTIONUS4761283
DESCRIPTIONUS4761372
DESCRIPTIONUS4808700
DESCRIPTIONUS4882317
DESCRIPTIONUS4965338
DESCRIPTIONUS5308835
DESCRIPTIONWO0010599
DESCRIPTIONWO02064162
DESCRIPTIONWO9814401
DESCRIPTIONWO9842375
SEARCHUS2005158334

Non-Patent Literature (NPL) Citations (46) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALIPAZAGA MVMORENO RGMCOICHEV N., "Synergistic effect of Ni(II) and Co(II) ions on the sulphite induced autoxidation of Cu(II)/tetraglycine complex.", Dalton Trans, (20040000), vol. 13, pages 2036 - 2040-
DESCRIPTION- BERGLUND JFRONAEUS SELDING LI, "Kinetics and mechanism for manganese-catalyzed oxidation of sulfur(IV) by oxygen in aqueous solution.", Inorg Chem, (19930000), vol. 32, pages 4527 - 4538-
DESCRIPTION- BURNOUF T, Vox Sang., (19910000), vol. 60, pages 8 - 15-
DESCRIPTION- CHEMICAL ABSTRACTS, Database accession no. 21645-51-2-
DESCRIPTION- EXLEY, C, Trends in Immunol., (20100000), vol. 31, pages 103 - 109-
DESCRIPTION- GEVER et al., Med. Microbiol. Immunol, (19790000), vol. 165, pages 171 - 288-
DESCRIPTION- HUIE R.E.NETA P., "One-electron redox reaction in aqueous solutions of sulphite with hydroquinone and other hydroxyphenols.", J. Phys. Chem., (19850000), vol. 89, no. 18, pages 3918 - 3921-
DESCRIPTION- ITO, KIMIKOKAWANASHI, SHOSUKE, "Site-specific fragmentation and modification of Albumin by sulphite in presence of metal ions or peroxidase/H202: Role of Sulphate radical.", Biochem and Biophys Res Comm., (19910000), vol. 176, pages 1306 - 1312-
DESCRIPTION- JONES et al., An. Acad. Bras. Cienc, (20050000), vol. 77, no. 2, pages 293 - 324-
DESCRIPTION- KALINA RANGUELOVAMARCELO G. BONINIRONALD P. MASON, "Bi)sulphite Oxidation by Copper,Zinc-Superoxide Dismutase: Sulphite- Derived, Radical-Initiated Protein Radical Formation.", Environmental Health Perspectives, (20100000), vol. 118, no. 7, pages 970 - 975-
DESCRIPTION- LAMBETH D.O.PALMER G., "The kinetics and mechanism of reduction of electron transfer proteins and other compounds of biological interest by dithionite.", J.Biochem. Chem., (19730000), vol. 248, pages 6095 - 6103-
DESCRIPTION- LIMA SBONIFACIO RLAZZELLINI GCCOICHEV N., "Ruthenium(II) tris(bipyridyl) ion as a luminescent probe for oxygen uptake on the catalyzed oxidation of HS03-.", Talanta, (20020000), vol. 56, pages 547 - 556-
DESCRIPTION- LIN C.-W.WU W.-C., J Virol., (20030000), vol. 77, no. 4, pages 2600 - 6-
DESCRIPTION- LINDBLAD, EB, Immunol. and Cell Biol., (20040000), vol. 82, pages 497 - 505-
DESCRIPTION- NETA P.HUIE R.E., Free Radical Chemistry of Sulphite. Environmental Health Perspectives, (19850000), vol. 64, pages 209 - 217-
DESCRIPTION- ROBBINS et al., JAMA, (19960000), vol. 276, no. 14, pages 1181 - 5-
DESCRIPTION- SHI X., "Generation of • SO and OH radicals in SO reactions with inorganic environmental pollutants and its implications to SO toxicity.", J Inorg Biochem, (19940000), vol. 56, no. 3, pages 155 - 165-
DESCRIPTION- LI SSCHONEICH CBORCHARDT RT., "Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization.", Biotechnol Bioeng., (19951205), vol. 48, no. 5, doi:10.1002/bit.260480511, pages 490 - 500, XP055040145
DESCRIPTION- STADTMAN ER., "Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences.", Free Radic Biol Med., (19900000), vol. 9, no. 4, doi:10.1016/0891-5849(90)90006-5, pages 315 - 25, XP023548593
DESCRIPTION- ARUNEE WITTAYANUKULLUKDONGPING JIANGFRED E. REGNIERSTANLEY L. HEM, "Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen", Vaccine, (20040000), vol. 22, doi:10.1016/j.vaccine.2003.09.037, pages 1172 - 1176, XP004493380
DESCRIPTION- MAYO JCTAN DXSAINZ RMNATARAJAN MLOPEZ-BURILLO SREITER RJ., "Protection against oxidative protein damage induced by metal-catalyzed reaction or alkylperoxyl radicals: comparative effects of melatonin and other antioxidants.", Biochim Biophys Acta, (20030317), vol. 1620, no. 1-3, doi:10.1016/S0304-4165(02)00527-5, pages 139 - 50, XP004410890
DESCRIPTION- BRANDT CELDING LI., "Role of chromium and vanadium in the atmospheric oxidation of sulfur (IV).", Atmos Environ, (19980000), vol. 32, no. 4, doi:10.1016/S1352-2310(97)00331-2, pages 797 - 800, XP004890864
EXAMINATION- European Pharmacopeia 7.0 Pages 114-117-
OPPOSITION- Anonymous, "ALUMINIUM CHLORIDE HEXAHYDRATE", EUROPEAN PHARMACOPOEIA 11.0, (20170101), pages 1 - 2, XP093259016-
OPPOSITION- Anonymous, "ALUMINIUM HYDROXIDE, HYDRATED, FOR ADSORPTION", EUROPEAN PHARMACOPOEIA 7.0, (20080401), pages 1357 - 1358, XP093259028-
OPPOSITION- Anonymous, "ALUMINIUM PHOSPHATE HYDRATE", EUROPEAN PHARMACOPOEIA 11.6, (20250101), page 1, XP093259018-
OPPOSITION- Anonymous, "ASSESSMENT REPORT FOR IXIARO, Procedure No. EMEA/H/C/000963", Emea, European Medicines Agency, (20090101), pages 1 - 50, XP093259024-
OPPOSITION- Anonymous, "Assessment report for IXIARO, Review under Article 20 of Regulation (EC) No 726/2004 ", EUROPEAN MEDICINES AGENCY, (20120525), pages 1 - 8, XP093259007-
OPPOSITION- Anonymous, "VACCINES FOR HUMAN USE, Vaccina ad usum humanum", EUROPEAN PHARMACOPOEIA 11.0, (20230101), pages 952 - 955, XP093259022-
OPPOSITION- D04: letter from EMA to EVM dated 15 December 2011*1-
OPPOSITION- D05: Emails exchanges with EMA/CHMP concerning D4*2-
OPPOSITION- D09: preliminary opinion of BoA in case T1684/20 dated 12 November 2021-
OPPOSITION- D13: Summary of Product Characteristics (SmPC) for DULTAVAX® 2010-
OPPOSITION- Patel Jalpa et al, "Stability Considerations for Biopharmaceuticals, Part 1 ", BioProcess international, (20110101), pages 20 - 30, XP093259037-
OPPOSITION- Traveladmin, "Vaccine Recall- IXIARO- Japanese Encephalitis", Travel Clinic Biog, (20110614), pages 1 - 2, XP093122223-
OPPOSITION- Stadtman, E.R., "Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences", Free Radical Biology & Medicine, Elsevier Inc, US, US , (19900101), vol. 9, no. 4, doi:10.1016/0891-5849(90)90006-5, ISSN 0891-5849, pages 315 - 325, XP023548593
OPPOSITION- Robert Schlegl et al, "Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO®", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20151101), vol. 33, no. 44, doi:10.1016/j.vaccine.2015.05.103, ISSN 0264-410X, pages 5989 - 5996, XP055315021
OPPOSITION- Srivastava, A.K. et al, "A purified inactivated Japanese encephalitis virus vaccine made in vero cells", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20010814), vol. 19, no. 31, doi:10.1016/S0264-410X(01)00208-0, ISSN 0264-410X, pages 4557 - 4565, XP004296120
OPPOSITION- Lin Cheng-Wen, Wu Suh-Chin, "A Functional Epitope Determinant on Domain III of the Japanese Encephalitis Virus Envelope Protein Interacted with Neutralizing-Antibody Combining Sites", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (20030215), vol. 77, no. 4, doi:10.1128/JVI.77.4.2600-2606.2003, ISSN 0022-538X, pages 2600 - 2606, XP093122000
SEARCH- Anonymous, "Aluminium hydroxide, hydrated, for adsorption", European Pharmacopoeia, (20110101), pages 3395 - 3396, XP055765255 [Y] 19-21 * the whole document *-
SEARCH- Emea, "Assesment report for IXIARO", (20090101), URL: http://www.ema.europa.eu/en/medicines/human/EPAR/ixiaro, (20210114), XP055765267 [Y] 19-21 * the whole document *-
SEARCH- "General Chemical. Rehydragel Adjuvants. Product profile", INTERNET CITATION, (20121009), pages 1 - 2, URL: http://www.generalchemical.com/assets/pdf/Rehydragel_Adjuvants_Product_Profile.pdf, (20121008), XP002684848 [T] * the whole document *-
SEARCH- SHIHONG LI ET AL, "Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization", BIOTECHNOLOGY AND BIOENGINEERING, (19951205), vol. 48, no. 5, doi:10.1002/bit.260480511, ISSN 0006-3592, pages 490 - 500, XP055040145 [A] 1-21 * abstract * * page 494 - page 495 * * page 497, column r, paragraph 3 *
SEARCH- TIA ESTEY ET AL, "Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry", JOURNAL OF PHARMACEUTICAL SCIENCES, (20090901), vol. 98, no. 9, doi:10.1002/jps.21543, ISSN 0022-3549, pages 2994 - 3012, XP055040203 [A] 1-21 * abstract * * page 2995, column l, paragraph 3 * * page 2997, column l, paragraph 2 - paragraph 3 * * page 3002 - page 3005 *
SEARCH- ROBERT SCHLEGL ET AL, "Influence of elemental impurities in aluminum hydroxide adjuvant on the stability of inactivated Japanese Encephalitis vaccine, IXIARO?", VACCINE, AMSTERDAM, NL, (20151101), vol. 33, no. 44, doi:10.1016/j.vaccine.2015.05.103, ISSN 0264-410X, pages 5989 - 5996, XP055315021 [T] * table 4 *
SEARCH- ERIK B LINDBLAD, "Aluminium compounds for use in vaccines", IMMUNOLOGY AND CELL BIOLOGY, CARLTON, AU, (20041001), vol. 82, no. 5, doi:10.1111/J.0818-9641.2004.01286.X, ISSN 0818-9641, pages 497 - 505, XP008151421 [A] 1-21 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents